On Oct. 25, leading innovators in healthcare will convene in Boston to attend the ninth annual Connected Health Conference. Widely considered one of the premier events in healthcare, this year’s conference will host over 2,000 attendees focused on changing the way the Country thinks about health and wellness. The Rx.Health team will be in Boston to engage, exhibit and speak throughout the 3-day conference.

“Every year we look forward to attending Connected Health, but after looking back at the success stories with our academic partners in 2017, we’re really excited to engage with other pioneers in healthcare and ed treatment,” said Rx.Health Cofounder and CEO, Ed Berde. “Health systems, payers and industry that wants to learn how to leverage a singular platform for innovation and clinical transformation should stop by Kiosk 101 at the Startup Pavilion to talk to my team. Our academic partners will be presenting on how Digital Prescribing platform has helped with readmission reduction, quality improvement (supporting MIPS) as well as patient-centered decision aids in different specialties ranging from cardiology to GI to cancer care.”

In an effort to collaborate with as many attendees as possible during the conference, the majority of Rx.Health’s core leadership team will be in attendance. Berde will be joined by Pavan Choksi, the VP of Corporate Development, and Mark Cittadino who heads Sales & Growth.

Scientific cofounder Dr. Ashish Atreja will also be in Boston for the event as a featured speaker. In addition to his Oct. 25 panel discussion centered on fueling the innovation economy in connected health industry, Dr. Atreja will also present on the final day of the conference to discuss protocols of a digital health pilot study. Using RxUniverse’s pilot at Mount Sinai Health System as a model, Dr. Atreja will touch on the implications and takeaways surrounding the success of that study, which surpassed its expected outcome by 200 percent. More details on that study are available at http://Rx.Health.

Dr. Atreja will also be presenting the results of a study conducted at Mount Sinai in which 60 patients with Chronic Heart Failure were asked to use two mobile apps to track blood pressure and weight. The study found that patients monitoring their condition with Digital Medicine were significantly less likely to be readmitted to the hospital within the first 30 days after a procedure. Among the 60 patients, the readmission rate during the study was just 10 percent, compared to Mount Sinai’s average of 22.8 percent and the national average of 25 percent. After the study concluded, 70 percent of participants continued to use Digital Medicine to track their blood pressure and weight.

CHC17 offers a unique opportunity to interact with a diverse audience of attendees, from members of academia to the investment community. The conference offers perhaps the clearest view of healthcare through the prism of innovation, highlighting trends and market dynamics captivating the industry.

Stop by Kiosk 101 in the startup pavilion to speak with our team, and be sure to catch Dr. Atreja’s talks on October 25 and 27.